By Mrinalika Roy and Michael Erman (Reuters) -Bristol Myers and Pfizer said on Thursday they will start selling their ...

Health-care companies fell after a lackluster round of earnings. Shares of medical-device maker Abbott Labs shares tumbled by more than 8% after it trimmed and narrowed its 2025 growth projections ...

The health sector is witnessing notable developments. Bristol Myers and Pfizer are offering Eliquis at a discounted rate.

Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.

GE Aerospace raised its full-year earnings outlook and beat expectations on its top and bottom lines in the second quarter. PepsiCo said its business remained resilient during the second quarter, ...

Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Pfizer (PFE), in collaboration with Bristol Myers Squibb, has introduced a direct-to-patient option for Eliquis®, potentially ...

GE Aerospace raised its full-year earnings outlook and beat expectations on its top and bottom lines in the second quarter. PepsiCo said its business remained resilient during the second quarter, ...

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

Netflix reports second-quarter earnings after the closing bell Thursday. Wall Street analysts surveyed by LSEG expect ...